Ambu and Xenocor over the past week each announced agreements with U.S. healthcare purchasing groups involving single-use scopes. Ambu said on October 7 that it won a national single-use endoscopy contract in the single-use endoscope category of a “major U.S. group-purchasing organization.” The deal enables Ambu to serve a fifth of the acute care hospitals […]
Ambu
Ambu, Boston Sci execs see domination for single-use scopes
Hospital closures connected to COVID-19 have cut into the sales of many medical device companies, but executives at rival makers of single-use scopes say pandemic has only heightened existing concerns about contamination, exposure and cost. In interviews in this week’s DeviceTalks Weekly Podcast, executives from Ambu A/S and Boston Scientific (NYSE:BSX) said improved technology make […]
Ambu lands national single-use endoscope contract
Ambu announced that it was awarded a single-use endoscopy contract in the category of surgical disposable scopes with Premier Inc. Columbia, Md.-based Ambu said in a news release that it was also the only supplier of single-use endoscopes designated to participate in Premier’s Surpass and Ascend purchasing programs. The three-year agreement creates a single-use endoscopy […]
FDA clears Ambu single-use duodenoscope
Ambu announced today that FDA has cleared its aScope Duodeno — a sterile, single-use duodenoscope meant to avoid the deadly superbug outbreaks that cropped up around reusable versions of the scopes. Other companies — including Boston Scientific (NYSE:BSX), Hoya’s (TYO:7741) Pentax subsidiary, and Olympus (TYO:7733) — have been releasing either fully disposable duodenoscopes or duodenoscopes with disporable endcaps […]
Ambu, Fuel Medical ink partnership deal
Ambu announced that it entered into a partnership with Fuel Medical Group to combine marketing and strategy with the latter’s endoscope technologies. Under the agreement, Columbia, Md.-based Ambu is set to offer Fuel Medical marketing, finance, digital strategy, development and recruiting services. In return, Camas, Wash.-based Fuel Medical will offer its single-use endoscopes, which include […]
Ambu to launch single-use endoscopy device
Ambu announced today that it will launch its Ambu aView 2 Advance display unit for use with endoscopes in Europe and the U.S. Denmark-based Ambu received CE Mark and FDA approval to market its portable, full-HD unit that combines with single-use endoscopes across multiple clinical areas. The Ambu aView 2 Advance connects with Ambu’s aScope […]
Ambu dives on spiked distributor deal, lowered outlook
Shares in Danish endoscope maker Ambu (CPH:AMBU-B) took a dive today in Copenhagen after it spiked its deal with a U.S. distributor and slashed its outlook on the rest of the year. The Ballerup, Denmark-based company said it’s planning to cut ties with Tri-anim Health Services on the U.S. sales of its aScope pulmonary endoscopes […]
Denmark’s Ambu settles U.S. trade violations for $3.3 million
Ambu A/S will pay $3.3 million to resolve allegations that it manufactured products in China and Malaysia for sale to U.S. government agencies in violation of the federal Trade Agreements Act (TAA), according to the U.S. Department of Justice. The government claims that the Danish medtech company submitted false claims to the Defense Logistics Agency […]
Ambu pays $261m for Invendo Medical
Ambu (CPH:AMBU-B) this week said it agreed to put $261 million on the table for Invendo Medical and its line of disposable endoscopy devices. Copenhagen-based Ambu said it paid $133.2 million (€115 million) up front for Invendo, with another $127.4 million (€110 million) in possible milestones. Those include a $81.1 million (€70 million) payment pegged to […]
Denmark’s Ambu pays $16m for ETView Medical
Ambu (CPH:AMBU-B) agreed to pay $16 million to acquire ETView Medical (TLV:TLV) and its portfolio of airway management devices. The deal calls for Copenhagen-based Ambu to put up $12.3 million in cash and the balance in debt in a “reverse triangular merger” in which Ambu will create a subsidiary, which will buy ETView then be absorbed by Ambu. ETView […]
